First Affiliated Hospital Of Guangxi Medical University
Clinical trials sponsored by First Affiliated Hospital Of Guangxi Medical University, explained in plain language.
-
New combo therapy aims to improve survival in advanced nose cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new drug (Becotatug vedotin) plus immunotherapy (sintilimab) and standard chemoradiation works better than current standard treatment for high-risk nasopharyngeal cancer. About 266 adults with advanced but non-spread cancer will be randomly assi…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New eye test criteria could speed up diagnosis of vision loss cause
Diagnosis Recruiting nowThis study looks at whether a new set of international criteria can accurately diagnose optic neuritis—a condition that causes sudden vision loss—in Chinese patients. Researchers will enroll 500 people with acute or subacute vision loss and compare the criteria's results against …
Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC